Terumo Corporation (4543) - Product Pipeline Analysis
Summary
Terumo Corporation (Terumo) is a medical technology company engaged in the manufacturing and selling of a wide range of innovative medical care products which include hospital and medical products, equipment and pharmaceuticals. The company has four reportable segments in which it operates namely, General hospital products, Cardiac and Vascular products, Blood Transfusion products and Consumer Healthcare products. The company's Research and Development (R&D) activities are principally into combining the seeds of new technologies in the demand throughout the world market to create a next-generation technology. It has its R&D facility situated in Japan. The company principally operates in Japan, Europe, America and Asia and others through its 43 subsidiaries and 21 associates. Terumo is headquartered in Tokyo, Japan.
This report is a source for data, analysis and actionable intelligence on the Terumo Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
Reasons to Buy
Summary
Terumo Corporation (Terumo) is a medical technology company engaged in the manufacturing and selling of a wide range of innovative medical care products which include hospital and medical products, equipment and pharmaceuticals. The company has four reportable segments in which it operates namely, General hospital products, Cardiac and Vascular products, Blood Transfusion products and Consumer Healthcare products. The company's Research and Development (R&D) activities are principally into combining the seeds of new technologies in the demand throughout the world market to create a next-generation technology. It has its R&D facility situated in Japan. The company principally operates in Japan, Europe, America and Asia and others through its 43 subsidiaries and 21 associates. Terumo is headquartered in Tokyo, Japan.
This report is a source for data, analysis and actionable intelligence on the Terumo Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Terumo Corporation - Business Description
Key Facts
Terumo Corporation - Major Products and Services
Terumo Corporation Pipeline Products by Equipment Type
Terumo Corporation Pipeline Products by Development Stage
Terumo Corporation Pipeline Products by Therapy Area
Terumo Corporation Pipeline Products by Trial Phase
Terumo Corporation Pipeline Products by Milestone Summary
Anaconda Endovascular Stent Graft
Product Status
Product Description
Product Milestone
Anaconda Endovascular Stent Graft Clinical Trial
DuraHeart II
Product Status
Product Description
MISAGO Self-expanding Stent System
Product Status
Product Description
Product Milestone
MISAGO Self-expanding Stent System Clinical Trial
Wrist Artery Guidewire
Product Status
Product Description
Terumo Corporation - Key Competitors
Terumo Corporation - Key Employees
Terumo Corporation - Key Employee Biographies
Terumo Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Aug 05, 2011: Terumo Wins Patent Suit Against B.Braun On Intravenous Catheter With Safety Device
Jul 28, 2011: Terumo Reports Net Sales Of JPY95.6 Billion In Q1 Fiscal 2012
May 11, 2011: Terumo Reports Net Sales Of JPY328.2 Billion In Fiscal 2011
May 04, 2011: B. Braun Prevails In Case Against Terumo For Introcan Safety IV Catheter Patent
Jan 27, 2011: Terumo Reports Net Sales Of JPY244.2 Billion In Nine Months Ended December 31, 2010
Nov 23, 2010: B. Braun Wins Patent Infringement Case Against Terumo For Introcan Safety IV Catheter
Oct 29, 2010: Terumo Reports Net Income Of JPY18.36 Billion In H1 Fiscal 2011
Aug 17, 2010: Terumo And Asahi Intecc To Launch Guidewire Tie-up
Aug 05, 2010: Terumo Reports Net Income Of JPY8.79 Billion In Q1 Fiscal 2011
Jul 05, 2010: TPC Likely To Expand Philippines Operations
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Terumo Corporation, Key Facts
Terumo Corporation Key Pipeline Products by Equipment Type
Terumo Corporation Key Pipeline Products by Therapy Area
Terumo Corporation Key Pipeline Products by Development Stage
Terumo Corporation Key Pipeline Products by Trial Phase
Terumo Corporation, Key Facts
Terumo Corporation, Major Products and Services
Terumo Corporation Number of Pipeline Products by Equipment Type
Terumo Corporation Pipeline Products by Equipment Type
Terumo Corporation Number of Pipeline Products by Development Stage
Terumo Corporation Pipeline Products by Development Stage
Terumo Corporation Number of Pipeline Products by Therapy Area
Terumo Corporation Pipeline Products by Therapy Area
Terumo Corporation Number of Pipeline Products by Trial Phase
Terumo Corporation Pipeline Products by Trial Phase
Terumo Corporation Number of Pipeline Products By Milestone Summary
Terumo Corporation Pipeline Products by Milestone Summary
Anaconda Endovascular Stent Graft - Product Status
Anaconda Endovascular Stent Graft - Product Description
Anaconda Endovascular Stent Graft - Product Milestone
Anaconda Endovascular Stent Graft - Vascutek Anaconda Stent Graft System For Infra-Renal Abdominal Aortic Aneurysm Repair-A Post-Market Surveillance Study
Anaconda Endovascular Stent Graft - The Early Canadian Experience With The Anaconda Endovascular Stent Graft For Infrarenal Aortic Aneurysm Repair
Anaconda Endovascular Stent Graft - The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Anaconda Endovascular Stent Graft - Patent Details
DuraHeart II - Product Status
DuraHeart II - Product Description
MISAGO Self-expanding Stent System - Product Status
MISAGO Self-expanding Stent System - Product Description
MISAGO Self-expanding Stent System - Product Milestone
MISAGO Self-expanding Stent System - MISAGO 1 Clinical Study
MISAGO Self-expanding Stent System - Prospective, Non-Randomised, Multi-Centre, Observational Study To Confirm The Performance Of Misago Peripheral Self-Expanding Stent System For The Treatment Of Occluded Or Stenotic Superficial Femoral Or Popliteal Arteries
MISAGO Self-expanding Stent System - Physician Initiated Multi-center Belgian-German Trial Investigating the Terumo Misago Stent in the Treatment of TASC A & B Iliac Lesions
MISAGO Self-expanding Stent System - e-MISAGO Registry - To Validate The Safety And Efficacy Of Misago Stent System In Real-World Patients
MISAGO Self-expanding Stent System - A Multi-center Clinical Trial of the Misago Self Expanding Stent System for Superficial Femoral Artery
Wrist Artery Guidewire - Product Status
Wrist Artery Guidewire - Product Description
Terumo Corporation, Key Employees
Terumo Corporation, Key Employee Biographies
Terumo Corporation, Other Locations
Terumo Corporation, Subsidiaries
LIST OF FIGURES
Terumo Corporation Key Pipeline Products by Equipment Type
Terumo Corporation Pipeline Products by Equipment Type
Terumo Corporation Pipeline Products by Development Stage
Terumo Corporation Pipeline Products by Therapy Area
Terumo Corporation Pipeline Products by Trial Phase
Terumo Corporation Pipeline Products by Milestone Summary
COMPANIES MENTIONED
Medtronic, Inc.
Jarvik Heart, Inc.
F. Hoffmann-La Roche Ltd.
Edwards Lifesciences Corporation
Cordis Corporation
BIOTRONIK SE & Co. KG
Becton, Dickinson and Company
Bayer HealthCare AG
ARKRAY, Inc.
ABIOMED, Inc.
Key Facts
Terumo Corporation - Major Products and Services
Terumo Corporation Pipeline Products by Equipment Type
Terumo Corporation Pipeline Products by Development Stage
Terumo Corporation Pipeline Products by Therapy Area
Terumo Corporation Pipeline Products by Trial Phase
Terumo Corporation Pipeline Products by Milestone Summary
Anaconda Endovascular Stent Graft
Product Status
Product Description
Product Milestone
Anaconda Endovascular Stent Graft Clinical Trial
DuraHeart II
Product Status
Product Description
MISAGO Self-expanding Stent System
Product Status
Product Description
Product Milestone
MISAGO Self-expanding Stent System Clinical Trial
Wrist Artery Guidewire
Product Status
Product Description
Terumo Corporation - Key Competitors
Terumo Corporation - Key Employees
Terumo Corporation - Key Employee Biographies
Terumo Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Aug 05, 2011: Terumo Wins Patent Suit Against B.Braun On Intravenous Catheter With Safety Device
Jul 28, 2011: Terumo Reports Net Sales Of JPY95.6 Billion In Q1 Fiscal 2012
May 11, 2011: Terumo Reports Net Sales Of JPY328.2 Billion In Fiscal 2011
May 04, 2011: B. Braun Prevails In Case Against Terumo For Introcan Safety IV Catheter Patent
Jan 27, 2011: Terumo Reports Net Sales Of JPY244.2 Billion In Nine Months Ended December 31, 2010
Nov 23, 2010: B. Braun Wins Patent Infringement Case Against Terumo For Introcan Safety IV Catheter
Oct 29, 2010: Terumo Reports Net Income Of JPY18.36 Billion In H1 Fiscal 2011
Aug 17, 2010: Terumo And Asahi Intecc To Launch Guidewire Tie-up
Aug 05, 2010: Terumo Reports Net Income Of JPY8.79 Billion In Q1 Fiscal 2011
Jul 05, 2010: TPC Likely To Expand Philippines Operations
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Terumo Corporation, Key Facts
Terumo Corporation Key Pipeline Products by Equipment Type
Terumo Corporation Key Pipeline Products by Therapy Area
Terumo Corporation Key Pipeline Products by Development Stage
Terumo Corporation Key Pipeline Products by Trial Phase
Terumo Corporation, Key Facts
Terumo Corporation, Major Products and Services
Terumo Corporation Number of Pipeline Products by Equipment Type
Terumo Corporation Pipeline Products by Equipment Type
Terumo Corporation Number of Pipeline Products by Development Stage
Terumo Corporation Pipeline Products by Development Stage
Terumo Corporation Number of Pipeline Products by Therapy Area
Terumo Corporation Pipeline Products by Therapy Area
Terumo Corporation Number of Pipeline Products by Trial Phase
Terumo Corporation Pipeline Products by Trial Phase
Terumo Corporation Number of Pipeline Products By Milestone Summary
Terumo Corporation Pipeline Products by Milestone Summary
Anaconda Endovascular Stent Graft - Product Status
Anaconda Endovascular Stent Graft - Product Description
Anaconda Endovascular Stent Graft - Product Milestone
Anaconda Endovascular Stent Graft - Vascutek Anaconda Stent Graft System For Infra-Renal Abdominal Aortic Aneurysm Repair-A Post-Market Surveillance Study
Anaconda Endovascular Stent Graft - The Early Canadian Experience With The Anaconda Endovascular Stent Graft For Infrarenal Aortic Aneurysm Repair
Anaconda Endovascular Stent Graft - The Anaconda Endovascular Graft US FDA Phase II Clinical Study
Anaconda Endovascular Stent Graft - Patent Details
DuraHeart II - Product Status
DuraHeart II - Product Description
MISAGO Self-expanding Stent System - Product Status
MISAGO Self-expanding Stent System - Product Description
MISAGO Self-expanding Stent System - Product Milestone
MISAGO Self-expanding Stent System - MISAGO 1 Clinical Study
MISAGO Self-expanding Stent System - Prospective, Non-Randomised, Multi-Centre, Observational Study To Confirm The Performance Of Misago Peripheral Self-Expanding Stent System For The Treatment Of Occluded Or Stenotic Superficial Femoral Or Popliteal Arteries
MISAGO Self-expanding Stent System - Physician Initiated Multi-center Belgian-German Trial Investigating the Terumo Misago Stent in the Treatment of TASC A & B Iliac Lesions
MISAGO Self-expanding Stent System - e-MISAGO Registry - To Validate The Safety And Efficacy Of Misago Stent System In Real-World Patients
MISAGO Self-expanding Stent System - A Multi-center Clinical Trial of the Misago Self Expanding Stent System for Superficial Femoral Artery
Wrist Artery Guidewire - Product Status
Wrist Artery Guidewire - Product Description
Terumo Corporation, Key Employees
Terumo Corporation, Key Employee Biographies
Terumo Corporation, Other Locations
Terumo Corporation, Subsidiaries
LIST OF FIGURES
Terumo Corporation Key Pipeline Products by Equipment Type
Terumo Corporation Pipeline Products by Equipment Type
Terumo Corporation Pipeline Products by Development Stage
Terumo Corporation Pipeline Products by Therapy Area
Terumo Corporation Pipeline Products by Trial Phase
Terumo Corporation Pipeline Products by Milestone Summary
COMPANIES MENTIONED
Medtronic, Inc.
Jarvik Heart, Inc.
F. Hoffmann-La Roche Ltd.
Edwards Lifesciences Corporation
Cordis Corporation
BIOTRONIK SE & Co. KG
Becton, Dickinson and Company
Bayer HealthCare AG
ARKRAY, Inc.
ABIOMED, Inc.